Sponsor | Phase | Indication | Registration |
Kazia Therapeutics | II | Glioblastoma | NCT03522298 |
Dana-Farber Cancer Institute | II | Breast cancer brain metastases (with Herceptin®) | NCT03765983 |
Alliance for Clinical Trials in Oncology | II | Brain metastases | (TBA) |
St Jude Children's Research Hospital | I | DIPG (childhood brain cancer) | NCT03696355 |